Disparities in health services for HIV/AIDS, hepatitis C virus, and sexually transmitted infections: Role of substance abuse treatment programs

Journal of Addiction Medicine

Volumn 3, Issue 2, 2009, Pages 95-102

  Brown, Lawrence S ^a,b,i   Kritz, Steven ^a   Muhammad, Adashima ^a   Bini, Edmund J ^c   Goldsmith, R Jeffrey ^d   Robinson, Jim ^e   Alderson, Donald ^f   Hasin, Deborah S ^g   Rotrosen, John ^h  

^a Addiction Research and Treatment Corporatio   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^g VA New York Harbor Healthcare System ^*  (United States)

^h NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Addiction Research and Treatment Corporation   (United States)

Author keywords

Disparities; Hepatitis C virus; HIV AIDS; Sexually transmitted infections; Substance abuse treatment

Indexed keywords

EID: 70349248067     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e318190f0e7     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention. HIV/AIDS surveillance report 2004. MMWR Morb Mortal Wkly Rep. 2005;16:1-46.
2. Centers for Disease Control and Prevention. Trends in HIV/AIDS diagnoses-33 states, 2001-2004. MMWR Morb Mortal Wkly Rep. 2005;54:1149-1153.
3. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep. 1998;47:1-39.
4. Centers for Disease Control and Prevention. Sexually transmitted diseases surveillance 2004. MMWR Morb Mortal Wkly Rep. 2005;1-160.
5. Weinick RM, Zuvekas SH, Cohen JW. Racial and ethnic differences in access to and use of health care services, 1977 to 1996. Med Care Res Rev. 2000;57(suppl 1):36-54.
6. Olden K, White SL. Health-related disparities: influence of environmental factors. Med Clin North Am. 2005;89:721-738.
7. Cargill VA, Stone VE. HIV/AIDS: a minority health issue. Med Clin North Am. 2005;89:895-912.
8. Centers for Disease Control and Prevention. Health disparities experienced by Black or African Americans-nited States. MMWR Morb Mortal Wkly Rep. 2005;54:1-3.
9. Centers for Disease Control and Prevention. Racial disparities in nationally notifiable diseases-nited States, 2002. MMWR Morb Mortal Wkly Rep. 2005;54:9-11.
10. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infection among injection drug users. Medicine. 1995;74:212-220.
11. Poulin C, Alary M, Bernier F, et al. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and HIV infection among drug users attending an STD/HIV prevention and needle-exchange program in Quebec City, Canada. Sex Transm Dis. 1999;26:410-420.
12. Plitt SS, Garfein RS, Gaydos CA, et al. Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis. 2005;32:446-453.
13. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113:97-106.
14. Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000;59:17-31.
15. Farrell M, Gowing L, Marsden J, et al. Effectiveness of drug dependence treatment in HIV prevention. Int J Drug Policy. 2005;16:67-75.
16. Strauss SM, Falkin GP, Vassilev Z, et al. A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat. 2002;22:55-62.
17. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Survey of Substance Abuse Treatment Services (N-SSATS), Arlington, VA: Synectics for Management Decisions, Inc., 2005. doi:10.3886/ICPSR04469.
18. Brown LS, Kritz SA, Goldsmith J, et al. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2006; 30:315-321.
19. Rotrosen J, Leshner A, Tai B, et al. The national drug abuse treatment clinical trials network-challenges and opportunities. NIDA Res Monogr Ser. 2002;182:2-17.
20. Brown LS, Kritz SA, Goldsmith RJ, et al. Health services for HIV/AIDS, hepatitis C virus, and sexually transmitted infections in substance abuse treatment programs. Public Health Rep. 2007;122: 441-451.
21. Board of Health Sciences Policy, Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: The National Academies Press; 2003.
22. US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd ed. Washington, DC: US Government Printing Office; 2000.
23. Kritz S, Brown LS, Goldsmith RJ, et al. States and substance abuse treatment programs: funding and guidelines for infection-related services. Am J Public Health. 2008;98:824-826.
24. Brown LS, Chu A, Nemoto T, et al. Human immunodeficiency virus infection in a cohort of intravenous drug users in New York City: demographic, behavioral, and clinical features. NY State J Med. 1989; 89:506-510.
25. Substance Abuse and Mental Health Services Administration (SAMHSA). Results From the 2005 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series: H-30, DHHS Publication No. (SMA) 06-4194. Rockville, MD: SAMHSA; 2006.
26. National Treatment Center Study. Clinical Trials Network Summary and Comparison Report. NTCS Report No. 10, Athens, GA: Institute for Behavioral Research, University of Georgia; 2005.